Rocky Mountain Ayre, Inc. announced that Dr. Gregory Sullivan has joined the Board of Directors of the company. In addition, Dr. Sullivan will also assume the role of Chief Executive Officer. Timothy Ayre will remain as President and Chief Financial Officer.

Dr. Sullivan is a Molecular Pharmacologist with over 25 years experience producing scientific opportunities. As the managing partner for the last decade of Sullivan Rajan LLC, he has identified preclinical and clinical assets with untapped commercial opportunity and assembled a team of investors, scientists, consultants, bankers and pharmaceutical partners to bring drugs to patients.